Published Date: 04/10/2023
Expiration Date: 03/07/2026
Trip Gulick returns to PRN to spotlight key research from the Conference on Retrovirology and Opportunistic Infections (CROI). Dr. Gulick will target the latest advances in HIV treatment, and prevention, as well as other pandemic diseases reported at the recent CROI 2023.
Roy M. Gulick, MD, MPH research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the ACTG and the HIV Prevention Trials Network (HPTN), sponsored by the NIH.